Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis

Documenti analoghi

• Is it safe to preserve uterus after live birth following progestin‐based fertility‐sparing treatment for endometrial cancer or atypical hyperplasia: A long‐term retrospective cohort study
  di: Yiqin Wang, et al.
  Pubblicazione: (2026)
• Ensuring safety first: GLP‐1RAs in reproductive and endometrial research
  di: Paola Viganò, et al.
  Pubblicazione: (2025)
• Association of oral contraceptives and risk of endometrial cancer: A systematic review and meta‐analysis
  di: András Harajka, et al.
  Pubblicazione: (2025)
• Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up
  di: Ya‐Ting Hsu, et al.
  Pubblicazione: (2025)
• The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
  di: Alberto Sola‐Leyva, et al.
  Pubblicazione: (2024)